|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE CONSOLIDATED
FINANCIAL STATEMENTS OF MEDPLUS, INC. AND SUBSIDIARIES AS OF AND FOR THE THREE
MONTH PERIOD ENDED APRIL 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JAN-31-2001
<PERIOD-END> APR-30-2000
<CASH> 2,843,674
<SECURITIES> 0
<RECEIVABLES> 3,091,854
<ALLOWANCES> 155,000
<INVENTORY> 336,272
<CURRENT-ASSETS> 7,250,700
<PP&E> 2,642,824
<DEPRECIATION> 1,458,013
<TOTAL-ASSETS> 11,794,911
<CURRENT-LIABILITIES> 6,123,284
<BONDS> 0
0
23,718
<COMMON> 0
<OTHER-SE> 3,614,182
<TOTAL-LIABILITY-AND-EQUITY> 11,794,911
<SALES> 1,376,345
<TOTAL-REVENUES> 2,900,422
<CGS> 1,557,620
<TOTAL-COSTS> 3,678,520
<OTHER-EXPENSES> (47,100)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 143,100
<INCOME-PRETAX> (847,100)
<INCOME-TAX> 0
<INCOME-CONTINUING> (847,100)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (847,100)
<EPS-BASIC> (0.15)
<EPS-DILUTED> (0.15)
</TABLE>
|
|